Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer

por Kollipara, Revathi, Schneider, Bryan, Radovich, Milan, Babu, Sunil, Kiel, Patrick J.
Publicado 2017

The Frequency of Mutations in Exon 11 of the c-kit Gene in Patients With Leukemia

por Hussain, Syed Rizwan, Babu, Sunil G, Naqvi, Hena, Singh, Pradyumn, Mahdi, Farzana
Publicado 2012

1-Naphthyl 9H-carbazole-4-sulfonate

por Arulmozhi, R., Vennila, Jasmine P., Babu, Sunil Manohar, Kavitha, Helen P., Manivannan, V.
Publicado 2008

Breast tuberculosis in immunocompetent patients at tertiary care center: A case series

por Kumar, Manoj, Chand, Gyan, Nag, Vijaya Lakshmi, Maurya, Anand Kumar, Rao, Ram Nawal, Agarwal, Shudhi, Babu, Sunil S, Dhole, Tapan N
Publicado 2012

The efficacy of diagnostic battery in Pott's disease: A prospective study

por Kumar, Manoj, Kumar, Raj, Srivastva, Arun Kumar, Nag, Vijaya Lakshmi, Krishnani, Narendra, Maurya, Anand Kumar, Dhole, Tapan N, Babu, Sunil G
Publicado 2014

The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors

por Durairaj, Chandrasekar, Chakrabarti, Jayeta, Ferrario, Cristiano, Hirte, Holger W., Babu, Sunil, Piha-Paul, Sarina A., Plotka, Anna, Hoffman, Justin, Shi, Haihong, Wang, Diane D.
Publicado 2021

Predictors and Prevalence of Pain and Its Management in Four Regional Cancer Hospitals in India

por Doyle, Katherine E., El Nakib, Shatha K., Rajagopal, M.R., Babu, Sunil, Joshi, Geeta, Kumarasamy, Vidya, Kumari, D. Priya, Chaudhuri, Prabir, Mohanthy, Sumita, Jatua, Debasish, Lohman, Diederik, Amon, Joseph J., Palat, Gayatri
Publicado 2017

Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine

por Pollyea, Daniel A., Pratz, Keith W., Wei, Andrew H., Pullarkat, Vinod, Jonas, Brian A., Recher, Christian, Babu, Sunil, Schuh, Andre C., Dail, Monique, Sun, Yan, Potluri, Jalaja, Chyla, Brenda, DiNardo, Courtney D.
Publicado 2022

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

por Licht, Christoph, Greenbaum, Larry A, Muus, Petra, Babu, Sunil, Bedrosian, Camille L, Cohen, David J, Delmas, Yahsou, Douglas, Kenneth, Furman, Richard R, Gaber, Osama A, Goodship, Timothy, Herthelius, Maria, Hourmant, Maryvonne, Legendre, Christophe M, Remuzzi, Giuseppe, Sheerin, Neil, Trivelli, Antonella, Loirat, Chantal
Publicado 2015

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

por Sweeney, Christopher J., Percent, Ivor J., Babu, Sunil, Cultrera, Jennifer L., Mehlhaff, Bryan A., Goodman, Oscar B., Morris, David S., Schnadig, Ian D., Albany, Costantine, Shore, Neal D., Sieber, Paul R., Guba, Susan C., Zhang, Wei, Wacheck, Volker, Donoho, Gregory P., Szpurka, Anna M., Callies, Sophie, Lin, Boris Kin, Bendell, Johanna C.
Publicado 2022

Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: CheckMate 153

por Waterhouse, David M., Garon, Edward B., Chandler, Jason, McCleod, Michael, Hussein, Maen, Jotte, Robert, Horn, Leora, Daniel, Davey B., Keogh, George, Creelan, Ben, Einhorn, Lawrence H., Baker, Justin, Kasbari, Samer, Nikolinakos, Petros, Babu, Sunil, Couture, Felix, Leighl, Natasha B., Reynolds, Craig, Blumenschein, George, Gunuganti, Vijay, Li, Ang, Aanur, Nivedita, Spigel, David R.
Publicado 2020

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced...

por Bidard, Francois-Clement, Kaklamani, Virginia G., Neven, Patrick, Streich, Guillermo, Montero, Alberto J., Forget, Frédéric, Mouret-Reynier, Marie-Ange, Sohn, Joo Hyuk, Taylor, Donatienne, Harnden, Kathleen K., Khong, Hung, Kocsis, Judit, Dalenc, Florence, Dillon, Patrick M., Babu, Sunil, Waters, Simon, Deleu, Ines, García Sáenz, José A., Bria, Emilio, Cazzaniga, Marina, Lu, Janice, Aftimos, Philippe, Cortés, Javier, Liu, Shubin, Tonini, Giulia, Laurent, Dirk, Habboubi, Nassir, Conlan, Maureen G., Bardia, Aditya
Publicado 2022

Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma

por Fowler, Nathan H., Samaniego, Felipe, Jurczak, Wojciech, Ghosh, Nilanjan, Derenzini, Enrico, Reeves, James A., Knopińska-Posłuszny, Wanda, Cheah, Chan Y., Phillips, Tycel, Lech-Maranda, Ewa, Cheson, Bruce D., Caimi, Paolo F., Grosicki, Sebastian, Leslie, Lori A., Chavez, Julio C., Fonseca, Gustavo, Babu, Sunil, Hodson, Daniel J., Shao, Spencer H., Burke, John M., Sharman, Jeff P., Law, Jennie Y., Pagel, John M., Miskin, Hari P., Sportelli, Peter, O'Connor, Owen A., Weiss, Michael S., Zinzani, Pier Luigi
Publicado 2021

Development and Evaluation of Active Case Detection Methods to Support Visceral Leishmaniasis Elimination in India

por Dubey, Pushkar, Das, Aritra, Priyamvada, Khushbu, Bindroo, Joy, Mahapatra, Tanmay, Mishra, Prabhas Kumar, Kumar, Ankur, Franco, Ana O., Rooj, Basab, Sinha, Bikas, Pradhan, Sreya, Banerjee, Indranath, Kumar, Manash, Bano, Nasreen, Kumar, Chandan, Prasad, Chandan, Chakraborty, Parna, Kumar, Rakesh, Kumar, Niraj, Kumar, Aditya, Singh, Abhishek Kumar, Kundan, Kumar, Babu, Sunil, Shah, Hemant, Karthick, Morchan, Roy, Nupur, Gill, Naresh Kumar, Dwivedi, Shweta, Chaudhuri, Indrajit, Hightower, Allen W., Chapman, Lloyd A C., Singh, Chandramani, Sharma, Madan Prasad, Dhingra, Neeraj, Bern, Caryn, Srikantiah, Sridhar
Publicado 2021